vimarsana.com
Home
Live Updates
Polyphor and EnBiotix Announce Dosing of First Patient in a
Polyphor and EnBiotix Announce Dosing of First Patient in a
Polyphor and EnBiotix Announce Dosing of First Patient in a First-in-Human Clinical Trial of Inhaled Murepavadin
Press release content from Accesswire. The AP news staff was not involved in its creation.
Related Keywords
Germany ,
Boston ,
Massachusetts ,
United States ,
Zurich ,
Züsz ,
Switzerland ,
Allschwil ,
Switzerland General ,
Swiss ,
Pharma Gmb ,
Enbiotix Gmb ,
Hernan Levett ,
Stephan Feldhaus ,
Enbiotix Inc ,
Polyphor Ltd ,
Cystic Fibrosis Foundation ,
Swiss Exchange ,
Flowr Technology ,
European Innovative Medicines Initiative ,
University Of Zurich ,
Inhalation Solution ,
Jeffrey Wager ,
Chief Executive Officer ,
Outer Membrane Protein Targeting Antibiotics ,
Business ,
Health ,
Clinical Trials ,
Cystic Fibrosis ,
Antibiotics ,
Europe ,
Polyphor Ag ,
Accesswire ,